PATENT CLAIM ANALYSIS

Application Number: 15746828
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "300000"]

Abstract:
The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof has an EP4 receptor antagonistic action, and is useful as an agent for the prophylaxis or treatment of EP4 receptor associated diseases (e.g., rheumatoid arthritis, aortic aneurysm (e.g. abdominal aortic aneurysm, thoracic aortic aneurysm, thoracoabdominal aortic aneurysm etc.), endometriosis, ankylosing spondylitis, inflammatory breast cancer etc.) and the like.

Claim (Index 2):
The compound or salt of  claim 1 , wherein\n G 1  is a carbon atom, G 2  is a carbon atom or a nitrogen atom, Ring A is pyridine or pyrimidine, each of which is optionally further substituted by 1 to 2 substituents selected from the group consisting of (a) a halogen atom, (b) a C 1-6  alkyl group, and (c) a C 3-10  cycloalkyl group, G 3  is an oxygen atom, NR 1  wherein R 1  is a C 1-6  alkyl group, methylene or a sulfur atom, X is ethylene optionally substituted by an oxo group, R 2  and R 3  are each a hydrogen atom or a C 1-6  alkyl group, or R 2  and R 3  are joined together to form a C 3-10  cycloalkane, R 4  is a hydrogen atom, Ring B is (1) a C 6-14  aromatic hydrocarbon ring optionally further substituted by 1 to 3 substituents selected from the group consisting of\n (a) a carboxy group, \n (b) a C 1-6  alkoxy-carbonyl group, \n (c) a cyano group, \n (d) a carbamoyl group, \n (e) a mono- or di-C 1-6  alkyl-carbamoyl group, \n (f) a mono- or di-C 1-6  alkoxy-carbamoyl group, \n (g) a mono- or di-C 7-16  aralkyloxy-carbamoyl group, \n (h) 5-tetrazolyl, and \n (i) a C1-6 alkoxy group, \n (2) a C 3-10  cycloalkane, or (3) a 5- to 10-membered aromatic heterocycle optionally further substituted by 1 to 3 C 1-6  alkyl groups,\n Ring C is a C 6-14  aromatic hydrocarbon ring, a C 3-10  cycloalkane or a 5- to 14-membered aromatic heterocycle, each of which is optionally further substituted by 1 to 3 substituents selected from the group consisting of \n (1) a halogen atom, \n (2) an optionally halogenated C 1-6  alkyl group, \n (3) a C 1-6  alkoxy group, and \n (4) a C 6-14  aryl group, and \n W is \n (1) a C 1-4  alkylene group optionally substituted by an oxo group, or (2) \u2014(CH 2 ) m1 \u2014O\u2014 wherein m1 is an integer of 0 to 3.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.55932
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15534855', '15820429', '14779347', '13853394', '16083295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7758467672829185
- 35 USC 102 Novelty (BERT): 0.5023627789356675
- Combined Prediction Score: 0.7484983684481934
- Mean Citation Score: 253.09679000000008
- Max Citation Score: 260.92844
- Similarity Product: 209.55940379977704

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test